We are working with pharma companies better than ever before, says top university patent dealmaker

In an exclusive interview, Adam Stoten, the of COO Oxford University Innovation - one of Europe’s largest tech transfer offices - explains the challenges of protecting and commercialising early-stage life sciences inventions


Get unlimited access to all IAM content